Crossmark

Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-026-09553-2

Published Online: 2026-03-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McIntosh, Jennifer G https://orcid.org/0000-0002-6655-0940
Goodwin, Belinda

Ait Ouakrim, Driss

Collins, Katelyn

Wilson, Carlene

Baxter, Nancy N.

Jiang, Joyce

Mahar, Robert K.

Flander, Louisa

Emery, Jon D

Chang, Shanton

Taylor, Natalie

Feletto, Eleonora

Lew, Jie-Bin

Canfell, Karen

Macrae, Finlay

Greenwell, Harry

Jenkins, Mark
Funding

Funding for this research was provided by:

National Health and Medical Research Council (ID: 2010268)
License Information

Text and Data Mining valid from 2026-03-20

Version of Record valid from 2026-04-29
More Information

Article History

Received: 22 September 2025

Accepted: 8 February 2026

First Online: 20 March 2026

Declarations

:

: This trial has received ethics approval from the University of Melbourne Human Research Ethics Committee, on the 12th March, 2025. Approval ID: 2025-31380-63704-4. The trial has been registered with the ANZCTR. Registration number: ACTRN12625000875404.

: Each member of the steering committee will be required to approve the publication of any results.

: MJ and FM are members of the NBCSP Clinical Advisory Group.JE is a member of the Clinical Advisory Board of Rhythm Biosciences Ltd.

Document is current

Any future updates will be listed below